Mahsulot tavsifi:

The Botnia study investigates the association between cardiovascular mortality and metabolic syndrome, focusing on factors such as arterial hypertension, hyperinsulinemia, glucose tolerance, elevated BMI, and dyslipidemia. The study highlights that over 50% of patients with essential hypertension exhibit some degree of insulin resistance. It also explores the impact of lifestyle and sympathetic nervous system activity on metabolic syndrome and hypertension, including the effects of moxonidine and metoprolol therapy on blood pressure, heart rate, glucose, and insulin levels.